Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Jan 29;30(4):699–709. doi: 10.1158/1055-9965.EPI-20-0604

Table 2:

Descriptive statistics by Race (N=570)

Race
 
Black (N=162)
White (N=408)
 
N (%) N (%) p-value
Age
50+ years 118 (72.8) 320 (78.4) 0.15
≤50 years 44 (27.2) 88 (21.6)
Insurance
Both 7 (4.9) 15 (4.1) 0.048*
Private 127 (88.2) 343 (93.5)
Public 10 (6.9) 9 (2.4)
Working Status
No 60 (40.0) 164 (41.8) 0.7
Yes 90 (60.0) 228 (58.2)
Distress
Under control 88 (55.3) 233 (57.4) 0.29
Some distress 44 (27.7) 124 (30.5)
High level of distress 27 (17.0) 49 (12.1)
Medication
AIs 96 (60.4) 254 (62.4) 0.65
Tamoxifen 63 (39.6) 153 (37.6)
BMI (categorized)
Overweight or Obese 130 (86.7) 225 (58.7) <0.0001***
Underweight or Normal 20 (13.3) 158 (41.3)
Physical Activity Level
Low 57 (38.5) 106 (27.5) 0.0065*
Moderate 76 (51.4) 204 (52.8)
High 15 (10.1) 76 (19.7)
Stage
I 72 (52.9) 231 (64.0) 0.075
II 51 (37.5) 101 (28.0)
III 13 (9.6) 29 (8.0)
Surgery type
Lumpectomy 55 (42.3) 182 (54.5) 0.18
Mastectomy 65 (50.0) 133 (39.8)
Both 8 (6.2) 17 (5.1)
No surgery 2 (1.5) 2 (0.6)
Chemotherapy
Yes 71 (48.3) 140 (36.2) 0.011*
No 76 (51.7) 247 (63.8)
Radiation
Yes 87 (64.4) 253 (68.2) 0.43
No 48 (35.6) 118 (31.8)
Daily sitting time
≤ 6 hours 90 (55.6) 237 (58.1) 0.58
> 6 hours 72 (44.4) 171 (41.9)
Marriage
Married or living with a partner 75 (46.3) 290 (71.4) <0.0001***
Single 87 (53.7) 116 (28.6)
Education
Less than college 31 (19.1) 49 (12.2) 0.033*
College or higher 131 (80.9) 352 (87.8)
Income
<100,000/year 102 (67.5) 165 (43.0) <0.0001***
>=100,000/year 49 (32.5) 219 (57.0)
Home
Apart 30 (20.0) 19 (4.9) <0.0001***
House 120 (80.0) 365 (95.1)
Mean ± SD Mean ± SD p-value

Age 57.4 ± 11.6 59.4 ± 10.8 0.044*
BMI 32.1 ± 7.1 27.3 ± 7.3 <0.0001***
Self-efficacy 45.0 ± 3.4 44.6 ± 4.3 0.32
Understand Participate in Care 14.9 ± 1.3 15.1 ± 1.5 0.25
Maintain Positive Attitude 14.7 ± 1.8 14.3 ± 2.1 0.038*
Obtaining information 15.3 ± 1.3 15.2 ± 1.5 0.29
Medication Concerns 11.8 ± 3.1 10.9 ± 2.9 0.0012**
Medication Necessity 14.1 ± 3.0 13.8 ± 3.0 0.29
Religiosity 32.2 ± 4.2 24.6 ± 7.5 <0.0001***
Health Literacy Screening 1.3 ± 2.0 0.7 ± 1.4 <0.0001***
Perceived Severity 40.9 ± 13.3 36.2 ± 14.6 0.0005***
Perceived Susceptibility 35.4 ± 15.4 38.7 ± 16.8 0.035*
Social support 83.3 ± 18.0 81.1 ± 18.3 0.2
Emotional Support 83.7 ± 18.0 81.9 ± 18.7 0.3
Tangible Support 82.8 ± 23.2 79.6 ± 23.7 0.15
Trust in primary care 76.0 ± 15.6 79.6 ± 14.8 0.0092***
Communication 33.0 ± 4.5 34.2 ± 5.0 0.0076**
Medical Mistrust 22.1 ± 5.2 19.7 ± 4.6 <0.0001***
Total Endocrine Symptoms 20.5 ± 11.7 17.2 ± 11.0 0.0023*
Vasomotor Symptoms 4.9 ± 3.6 3.8 ± 3.7 0.0018**
NeuropsychologicalNeuropsychological Symptoms 3.8 ± 3.3 2.8 ± 2,8 0.0017**
Gastrointestinal Symptoms 4.5 ± 3.7 3.3 ± 3.2 0.0015**
Gynecological Symptoms 4.9 ± 3.9 4.9 ± 4.0 0.94
Bone Symptoms 2.3 ± 1.8 2.3 ± 2.0 0.88

Note: N=sample size; SD=standard deviation

T-tests were used for continuous variables and chi-square tests were used for categorical variables

*

p<0.05,

**

p<0.01,

***

p<0.001.